로딩 중…
지수 로딩 중…
Alumis Inc. Common Stock
ALMS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$23.41+1.56%
2026-06-18
Price Chart
Alumis Inc. Common Stock+677.74%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.98B |
| Revenue | $8M |
| Net Income | $-237M |
| Total Assets | $672M |
| Net Assets | $567M |
| Value | |
| P/B | 5.26x |
| P/S | 355.22x |
| FCF Yield | -12.63% |
| Profitability | |
| ROE | -41.87% |
| ROA | -35.35% |
| Op. Margin | -5364.02% |
| Revenue Growth | -89.99% |
| Financial Health | |
| Debt Ratio | 18.44% |
| Total Debt | $36M |
| FCF | $-377M |
| Cash | $64M |
| Current Ratio | 7.51x |
| Performance | |
| 1Y Return | 677.74% |
| 1M Return | 8.73% |
| From 52W High | -23.50% |
| 1Y MDD | -72.19% |
| Trading | |
| Volume | 1,774,889 shares |
| Trading Value | $42M |
| Per Share | |
| EPS | $-2.32 |
| BPS | $2.88 |